Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1140558

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kawasaki Disease: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what support his Department is providing to (a) enable early treatment and (b) increase awareness amongst healthcare providers of Kawasaki disease .
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	279382
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>NHS Improvement has previously published a Patient Safety Alert for the attention of providers of National Health Service-funded care to emphasise the high risk and atypical presentation of coronary artery aneurysms, coronary thrombosis and myocardial ischaemia or infarction in patients with Kawasaki disease, and to highlight the importance of specialist advice.</p><p>Guidance is also available from the National Institute for Health and Care Excellence (NICE) on the assessment and initial management of fever in children under five, and this guidance includes recommendations on recognising the symptoms of Kawasaki disease.</p><p>NICE’s clinical guidelines help healthcare professionals deliver the best possible care based on the best available evidence; the guidelines are not mandatory, although health and care commissioners are expected to take them fully into account.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:37:42 answering member 4455 label Biography information for Seema Kennedy previous answer version 131090 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1400 label Biography information for Kevin Brennan

1140559

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kawasaki Disease: Medical Records
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of establishing a patient registry on Kawasaki disease.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	279383
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>No such assessment has been made.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:41:26 answering member 4455 label Biography information for Seema Kennedy previous answer version 131091 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1400 label Biography information for Kevin Brennan

1140560

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kawasaki Disease: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent comparative assessment he has made of the UK level of research funding into Kawasaki disease with that of other EU member states.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	279384
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>The Department has not made a recent comparative assessment of the United Kingdom level of research funding into Kawasaki disease with that of other European Union member states.</p><p> </p><p>The EU has recently agreed to fund a Kawasaki disease study led from Great Ormond Street Hospital/University College London. The trial, which aims to recruit 262 children from 40 centres across Europe, will look at the effectiveness of using of steroids in addition to the standard treatment for Kawasaki syndrome, intravenous immunoglobulins. The award is for over €5 million in funding for the trial to be run through a new European consortium, connect4children.</p><p> </p><p>The National Institute for Health Research (NIHR) Imperial Biomedical Research Centre was funded between 2013-18 to carry out a project on the ‘Genetic determinants of Kawasaki disease for susceptibility and outcome’ with NIHR funding of £77,000.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 25/07/2019 14:19:10 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 131092 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1400 label Biography information for Kevin Brennan

1140577

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Department of Health and Social Care: Credit Unions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 July 2019 to Question 271334, for what reasons his Department does not offer a payroll deduction service to enable employees to join a credit union; and if he will make a statement.
tabling member constituency	Harrow West
tabling member printed	Gareth Thomas
uin	279367
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>Access to credit unions through payroll is something that has been explored and for which we plan further work to be undertaken in the future to assess if this will be implemented<em>.</em></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 25/07/2019 14:21:51 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	177 label Biography information for Gareth Thomas

1140582

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to issue guidance to health professionals on the Serious Shortage Protocol.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	279389
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>A Serious Shortage Protocol is an additional tool to manage serious medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>At present we are currently working on the governance process for developing Serious Shortage Protocols, should one be required, through engagement, including with professional bodies and patient groups. Following this we will issue guidance to health professionals in due course.</p><p>The Pharmaceutical Services Negotiating Committee, the organisation who represent National Health Service community pharmacy contractors in England, have developed a briefing note to support community pharmacies, who will need to consider training and changes to their standard operating-procedures to take account of the potential new processes.</p><p>Any Serious Shortage Protocol would be developed by senior, specialist doctors and pharmacists, with input from national experts, Royal Colleges and specialist societies. If a Serious Shortage Protocol is to be authorised then there will also be engagement with the relevant patient groups, who can assist in informing patients. Pharmacists still have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate and provide the patient with relevant information. If they determine supply is not appropriate, then the patient should be referred back to their prescriber.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:34:54 answering member 4455 label Biography information for Seema Kennedy previous answer version 131086 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1439 label Biography information for Norman Lamb

1140584

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans the Government has provide information to patients on changes to the provision of medicines as a result of the serious shortage protocol; and if he will make a statement.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	279390
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>A Serious Shortage Protocol is an additional tool to manage serious medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>At present we are currently working on the governance process for developing Serious Shortage Protocols, should one be required, through engagement, including with professional bodies and patient groups. Following this we will issue guidance to health professionals in due course.</p><p>The Pharmaceutical Services Negotiating Committee, the organisation who represent National Health Service community pharmacy contractors in England, have developed a briefing note to support community pharmacies, who will need to consider training and changes to their standard operating-procedures to take account of the potential new processes.</p><p>Any Serious Shortage Protocol would be developed by senior, specialist doctors and pharmacists, with input from national experts, Royal Colleges and specialist societies. If a Serious Shortage Protocol is to be authorised then there will also be engagement with the relevant patient groups, who can assist in informing patients. Pharmacists still have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate and provide the patient with relevant information. If they determine supply is not appropriate, then the patient should be referred back to their prescriber.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 279391 question first answered 26/07/2019 11:36:12 answering member 4455 label Biography information for Seema Kennedy previous answer version 131087 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1439 label Biography information for Norman Lamb

1140585

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions the Government has had with (a) patient groups and (b) professional bodies on the development of the serious shortage protocol.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	279391
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>A Serious Shortage Protocol is an additional tool to manage serious medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>At present we are currently working on the governance process for developing Serious Shortage Protocols, should one be required, through engagement, including with professional bodies and patient groups. Following this we will issue guidance to health professionals in due course.</p><p>The Pharmaceutical Services Negotiating Committee, the organisation who represent National Health Service community pharmacy contractors in England, have developed a briefing note to support community pharmacies, who will need to consider training and changes to their standard operating-procedures to take account of the potential new processes.</p><p>Any Serious Shortage Protocol would be developed by senior, specialist doctors and pharmacists, with input from national experts, Royal Colleges and specialist societies. If a Serious Shortage Protocol is to be authorised then there will also be engagement with the relevant patient groups, who can assist in informing patients. Pharmacists still have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate and provide the patient with relevant information. If they determine supply is not appropriate, then the patient should be referred back to their prescriber.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 279390 question first answered 26/07/2019 11:36:13 answering member 4455 label Biography information for Seema Kennedy previous answer version 131085 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1439 label Biography information for Norman Lamb

1140586

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Migraines: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure the adequacy of provision of treatment for people with migraines.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	279402
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>The majority of patients with migraine can be managed through routine access to primary and secondary care. Migraine management is identified within the core competencies for the care for people with neurological conditions in the Royal College of General Practitioners’ (RCGP) GP curriculum. Migraines are also identified as an key area of clinical knowledge in the RCGP Applied Knowledge Test (AKT) content guide. The AKT is a summative assessment of the knowledge base that underpins general practice in the United Kingdom within the context of the National Health Service and is a key part of GPs’ qualifying exams. <br></p><p>The National Institute for Health and Care Excellence (NICE) guideline, ‘Headaches: Diagnosis and management of headaches in young people and adults’, published in 2012 and updated in 2015, sets out evidence based best practice for healthcare professionals in the care, treatment and support of people who suffer from migraines.</p><p> </p><p>The usual treatment approaches to migraine are designed to either stop or prevent attacks. Treatments for acute migraine attacks include medications such as analgesics, triptans and anti-emetics (as recommended in NICE's guideline on headaches in over 12s).</p><p>Treatments to stop or reduce the frequency of migraine attacks include medications such as beta blockers, tricyclic antidepressants and antiepileptics.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:39:12 answering member 4455 label Biography information for Seema Kennedy previous answer version 131084 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1604 label Biography information for Mr Virendra Sharma

1140593

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Migrants
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what criteria his Department uses to estimate the average cost per year in England on treating non-EEA surcharge payers.
tabling member constituency	Vauxhall
tabling member printed	Kate Hoey
uin	279372
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>The estimate of the average cost per year in England of treating non-European Economic Area surcharge payers is based on the actual costs of treating surcharge payers in secondary care, and estimates for other National Health Service services based on age, gender and other demographics relative to the general population in England.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 25/07/2019 14:40:39 answering member 1585 label Biography information for Stephen Hammond
tabling member	210 label Biography information for Baroness Hoey

1140602

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 19 July 2019 to Question 273399 on HIV Infection: Salford, if he will take steps to ensure that gay and bisexual men in Salford have access to PrEP.
tabling member constituency	Salford and Eccles
tabling member printed	Rebecca Long Bailey
uin	279454
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>The pre-exposure prophylaxis (PrEP) Impact Trial is managed by the Trial Sponsor. Recruitment to places in the Trial is managed locally by participating clinics. Following funding from NHS England to pay for extra PrEP drug and research costs and the my Rt. hon Friend the Secretary of State for Health and Social Care’s announcement on 30 January that the number of places on the PrEP Impact Trial would be doubled to 26,000, expansion of the Trial is now underway across the country. Participation in the Trial is on a voluntary basis and it is for research clinics and local authorities to decide whether they wish to take part and the number of allocated places they can accept.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 12:17:05 answering member 4455 label Biography information for Seema Kennedy
tabling member	4396 label Biography information for Rebecca Long Bailey